Chargement en cours...
Higher anti‐tumour efficacy of platinum(IV) complex LA‐12 is associated with its ability to bypass M‐phase entry block induced in oxaliplatin‐treated human colon cancer cells
OBJECTIVES: Therapeutic potential of conventionally used platinum‐based drugs in treatment of colorectal tumours has been limited due to high incidence of tumour resistance to them and to their severe side effects. This evokes a search for more suitable anti‐cancer drugs. We have compared ability of...
Enregistré dans:
| Publié dans: | Cell Prolif |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6496914/ https://ncbi.nlm.nih.gov/pubmed/24118195 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cpr.12061 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|